<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="discussion">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2021.756408</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Opinion</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Membrane-Water Partition Coefficients of Antifungal, but Not Antibacterial, Membrane-Active Compounds Are Similar</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Volynsky</surname> <given-names>Pavel E.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1161755/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Smirnova</surname> <given-names>Alexandra I.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/802322/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Akimov</surname> <given-names>Sergey A.</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sokolov</surname> <given-names>Svyatoslav S.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/802198/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Severin</surname> <given-names>Fedor F.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/74093/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Laboratory of Biomolecular Modeling, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences (RAS)</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Molecular Energetics of Microorganisms, Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff>
<aff id="aff3"><sup>3</sup><institution>Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff>
<aff id="aff4"><sup>4</sup><institution>Laboratory of Bioelectrochemistry, A.N. Frumkin Institute of Physical Chemistry and Electrochemistry, Russian Academy of Sciences (RAS)</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Jack Wong, Caritas Institute of Higher Education, Hong Kong SAR, China</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Ioannis Konstantinos Kostakis, National and Kapodistrian University of Athens, Greece; Cheng-He Zhou, Southwest University, China</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Fedor F. Severin  <email>severin&#x00040;belozersky.msu.ru</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>11</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>756408</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>10</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2021 Volynsky, Smirnova, Akimov, Sokolov and Severin.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Volynsky, Smirnova, Akimov, Sokolov and Severin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license> </permissions>
<kwd-group>
<kwd>sterol</kwd>
<kwd>membrane</kwd>
<kwd>pore</kwd>
<kwd>antibacterial</kwd>
<kwd>antifungal</kwd>
</kwd-group>
<contract-sponsor id="cn001">Russian Science Foundation<named-content content-type="fundref-id">10.13039/501100006769</named-content></contract-sponsor>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="28"/>
<page-count count="4"/>
<word-count count="2578"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Sterols are essential components of eukaryotic membranes and play a structural role, increasing the resistance of the phospholipid bilayer to various stresses (Evans and Rawicz, <xref ref-type="bibr" rid="B8">1990</xref>; Zhelev and Needham, <xref ref-type="bibr" rid="B28">1993</xref>; Michalak et al., <xref ref-type="bibr" rid="B17">2013</xref>; Hannesschlaeger et al., <xref ref-type="bibr" rid="B12">2019</xref>). Concentrations of sterols are especially high in the plasma membrane, typically comprising 30&#x02013;40% of the total lipid content (Ejsing et al., <xref ref-type="bibr" rid="B7">2009</xref>; Subczynski et al., <xref ref-type="bibr" rid="B23">2017</xref>). Most prokaryotes lack sterol biosynthesis machinery and thus their plasma membranes are sterol-free. Many antimicrobial drugs disrupt the plasma membrane phospholipid bilayer. Here we ask whether antifungal and antibacterial compounds are fundamentally different in their physico-chemical properties which reflect their interactions with plasma membranes with distinct lipid compositions. A drug-membrane interaction can be divided into two stages: first, a drug moves from the aqueous phase into the water-membrane interface saturated by polar and charged groups. Next, it penetrates into the hydrophobic core of the phospholipid bilayer. Thus, we estimated the energy costs of these two steps for the antibacterial and antifungal compounds commonly used for medical and/or agricultural purposes. We have deliberately limited our analysis to such practically used compounds because their biological activities are, obviously, characterized more thoroughly than the ones of the chemicals used, for instance, for research purposes only. It appeared that while antibacterial compounds differed considerably in terms of the energy costs, antifungal compounds displayed a significant degree of similarity. This finding suggests a common mechanism for the interaction between the antifungal membrane-active compounds and the fungal plasma membrane.</p>
<sec>
<title>Sterols Stabilize Membranes by Preventing Pore Formation</title>
<p>While bacteria do not possess sterol biosynthesis machinery and thus are typically devoid of sterols, in eukaryotes sterols may reach up to 50 mol.% of total lipids in the plasma membrane (Mouritsen and Zuckermann, <xref ref-type="bibr" rid="B18">2004</xref>; Ejsing et al., <xref ref-type="bibr" rid="B7">2009</xref>; Subczynski et al., <xref ref-type="bibr" rid="B23">2017</xref>). Sterols are especially efficient in increasing the resistance of lipid bilayers with respect to lysis via pore formation caused by the membrane-active chemicals (Sot et al., <xref ref-type="bibr" rid="B21">2014</xref>; Mattei et al., <xref ref-type="bibr" rid="B16">2015</xref>; Carit&#x000E1; et al., <xref ref-type="bibr" rid="B4">2017</xref>). The mechanism of this protection can be illustrated using the example of lyso-forms of phosphocholine lipids. These compounds are similar to regular phosphocholine lipids but lack one of two hydrophobic tails of the molecule. Thus, while the molecules of the regular phosphocholine lipids are of cylindrical or slightly conical shape, the shape of the lysolipid derivatives is inverse conical with the wider polar side positioned close to the membrane-water interface (Fuller and Rand, <xref ref-type="bibr" rid="B11">2001</xref>). Such an arrangement leads to the alteration of the lipid monolayer curvature favoring pore formation (see <xref ref-type="fig" rid="F1">Figure 1A</xref>). The effective shape of sterol molecules is also non-cylindrical&#x02014;they are rather conical, and the base of the cone is typically embedded into the hydrophobic core (Fuller and Rand, <xref ref-type="bibr" rid="B11">2001</xref>; Kollmitzer et al., <xref ref-type="bibr" rid="B15">2013</xref>). In this way sterols can compensate for the curvature alterations caused by the lysolipids, preventing pore formation and irreversible membrane rupture (<xref ref-type="fig" rid="F1">Figure 1A</xref>) (Karpunin et al., <xref ref-type="bibr" rid="B14">2005</xref>; Strandberg et al., <xref ref-type="bibr" rid="B22">2012</xref>). Most membrane-active compounds, e.g., amphipathic antimicrobial peptides, disrupt membranes in a manner similar to lysolipids: in relatively high concentrations they act as a classic surfactant leading to micellization of the membrane; in lower concentrations pores are readily formed in the membrane (Tamba et al., <xref ref-type="bibr" rid="B25">2010</xref>; Henderson et al., <xref ref-type="bibr" rid="B13">2016</xref>; P&#x000E9;rez-Peinado et al., <xref ref-type="bibr" rid="B19">2018</xref>). This makes sterols rather universal compounds in terms of preventing pore formation in eukaryotic membranes.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>(A)</bold> sterols protect membrane against pore formation caused by lysolipids and similar compounds. <bold>(B)</bold> the water-octanol (WAT-OCT) and the octanol-cyclohexane (OCT-CHX) change in energy of the compounds with antibacterial (AB, red), antifungal (AF, blue), and the dual activity (AB, AF, green). See text for details.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmicb-12-756408-g0001.tif"/>
</fig>
<p>As prokaryotic membranes, unlike fungal ones, typically lack sterols, we reasoned that the membrane-active compounds targeting these groups are likely to be fundamentally different.</p>
</sec>
<sec>
<title>Antifungal Membrane-Active Compounds Display Higher Similarity in Physico-Chemical Properties Than Antibacterial Compounds</title>
<p>To test this hypothesis, we first compiled a list of antifungal, antibacterial or the dual activity compounds targeting the outer membrane, which are used in medicine and/or agriculture (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Most of them are listed in four comprehensive reviews (Fait et al., <xref ref-type="bibr" rid="B9">2019</xref>; Falk, <xref ref-type="bibr" rid="B10">2019</xref>; Zhang and Ma, <xref ref-type="bibr" rid="B27">2019</xref>; Anestopoulos et al., <xref ref-type="bibr" rid="B2">2020</xref>). An additional literature search for such compounds added Brilliant Green and Chlorhexidine gluconate (general antimicrobial antiseptics) to our list. Also, Lytixar and Brilacidin were included according to Zhang et al. (<xref ref-type="bibr" rid="B26">2018</xref>), and Morpholine, 4-dodecyl-, 4-oxide were added based on (&#x00160;ub&#x000ED;k et al., <xref ref-type="bibr" rid="B24">2021</xref>). Membrane-active compounds which display additional activities, e.g., oxolinic acid, which is also a DNA-gyrase inhibitor, were not included in the list. Next, we tried to characterize the basic features of their interaction with phospholipid bilayers.</p>
<p>A first step of an interaction between a chemical compound and a phospholipid bilayer is a transition between the aqueous phase to the aqueous-hydrophobic interface. Second, the chemical enters the hydrophobic phase of the membrane. Thus, to characterize the interaction we calculated the free energy changes for both of the transitions (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The energies of interaction of each chemical with the media were calculated as the sums of accessible surface areas of the atoms, weighted by the atomic solvation parameter (ASP) for different solvents. ASPs have been calculated based on the distribution of amino acids between different liquids. This approach has been successfully tested in the study of interactions of proteins with membranes (Efremov et al., <xref ref-type="bibr" rid="B6">1999</xref>). To mimic aqueous and inner membrane media we have used ASP sets for water and cyclohexane, respectively. To estimate the energy on the water-membrane interface we used an ASP set for octanol, which to some extent emulates this medium (Allen, <xref ref-type="bibr" rid="B1">2007</xref>). Next, we plotted these values: Y-axis shows the water-octanol (WAT-OCT) change in energy, X-axis shows the octanol-cyclohexane (OCT-CHX) differences (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The values corresponding to the compounds with the antibacterial activity (AB) only are shown in red, the ones corresponding to the chemicals with antifungal (AF) activity are shown in blue, the ones with the dual activity (AB, AF) are shown in green. By looking at the graph one can easily notice that the antifungal compounds display a much higher degree of clustering than the antibacterial ones. One of the antifungal compounds outside the cluster (green dot on the left hand side, <xref ref-type="fig" rid="F1">Figure 1B</xref>) corresponds to Lytixar, the activity of which depends on sphingolipids (Bojsen et al., <xref ref-type="bibr" rid="B3">2013</xref>). The mechanism of action of the other outlier, Dimethyldioctadecylammonium bromide (the right hand side of the graph), is also a rather special one. It does not simply disrupt the fungal plasma membrane, but makes its antigens more accessible to the immune system (De Serrano and Burkhart, <xref ref-type="bibr" rid="B5">2017</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="s2">
<title>Discussion</title>
<p>The clustering of the compounds with antifungal activity obviously suggests a common mechanism of their action. Analysis of the literature suggests that simple lysis of cells is not such a mechanism. Rather than puncturing the plasma membrane, these compounds seem to induce intracellular changes: inhibit the hyphal growth and/or biofilm formation, cause ROS generation, etc. (reviewed Fait et al., <xref ref-type="bibr" rid="B9">2019</xref>; Falk, <xref ref-type="bibr" rid="B10">2019</xref>; Zhang and Ma, <xref ref-type="bibr" rid="B27">2019</xref>; Anestopoulos et al., <xref ref-type="bibr" rid="B2">2020</xref>). This is consistent with the protective role of ergosterol against pore formation (<xref ref-type="fig" rid="F1">Figure 1A</xref>). As the clustered compounds contain positively charged quaternary amine groups within their structures, one may suggest that they can bind to anionic xenobiotics and thus facilitate their penetration through the plasma membrane by neutralizing the negative charge. Importantly, a number of fatty acids do possess antifungal activity. The list includes palmitic, lauric, arachidonic and the other major fatty acids present in animals and plants. Among other activities, they inhibit the biosynthesis of ergosterol and induce ROS generation in fungal cells. One can easily imagine that, for instance, the benzalkonium cation binds to palmitic acid and this facilitates its transport across the phospholipid bilayer&#x02014;a phenomenon which has been already shown by us for a quaternary phosphonium-based compound (Severin et al., <xref ref-type="bibr" rid="B20">2010</xref>). Regardless of whether this explanation is correct or not, the clustering illustrated by <xref ref-type="fig" rid="F1">Figure 1B</xref> suggests a novel approach for identifying novel antifungals. For instance, one can consider <italic>in silico</italic> screening of FDA-approved chemicals with physico-chemical properties similar to those of the compounds within the antifungal cluster. The data provided by this paper suggest that each such chemical may be a potential candidate for re-profiling as an antifungal.</p>
</sec>
<sec id="s3">
<title>Author Contributions</title>
<p>FS and SS drafted the manuscript. PV, AS, and SA participated in the initial observations and discussion. All authors were involved in literature search and editing of the manuscript.</p>
</sec>
<sec sec-type="funding-information" id="s4">
<title>Funding</title>
<p>This work was supported by the Russian Science Foundation (grant No. 18-14-00151).</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s5">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname> <given-names>T. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Modeling charged protein side chains in lipid membranes</article-title>. <source>J. Gen. Physiol.</source> <volume>130</volume>, <fpage>237</fpage>&#x02013;<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.200709850</pub-id><pub-id pub-id-type="pmid">17635964</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anestopoulos</surname> <given-names>I.</given-names></name> <name><surname>Kiousi</surname> <given-names>D. E.</given-names></name> <name><surname>Klavaris</surname> <given-names>A.</given-names></name> <name><surname>Galanis</surname> <given-names>A.</given-names></name> <name><surname>Salek</surname> <given-names>K.</given-names></name> <name><surname>Euston</surname> <given-names>S. R.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Surface active agents and their health-promoting properties: molecules of multifunctional significance</article-title>. <source>Pharmaceutics</source> <volume>12</volume>:<fpage>688</fpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics12070688</pub-id><pub-id pub-id-type="pmid">32708243</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bojsen</surname> <given-names>R.</given-names></name> <name><surname>Torbensen</surname> <given-names>R.</given-names></name> <name><surname>Larsen</surname> <given-names>C. E.</given-names></name> <name><surname>Folkesson</surname> <given-names>A.</given-names></name> <name><surname>Regenberg</surname> <given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>The synthetic amphipathic peptidomimetic LTX109 is a potent fungicide that disturbs plasma membrane integrity in a sphingolipid dependent manner</article-title>. <source>PLoS ONE</source> <volume>8</volume>:<fpage>e69483</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0069483</pub-id><pub-id pub-id-type="pmid">23874964</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carit&#x000E1;</surname> <given-names>A.</given-names></name> <name><surname>Mattei</surname> <given-names>B.</given-names></name> <name><surname>Domingues</surname> <given-names>C.</given-names></name> <name><surname>Paula</surname> <given-names>E.</given-names></name> <name><surname>Riske</surname> <given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Effect of Triton X-100 on raft-like lipid mixtures: phase separation and selective solubilization</article-title>. <source>Langmuir</source> <volume>33</volume>, <fpage>7312</fpage>&#x02013;<lpage>7321</lpage> <pub-id pub-id-type="doi">10.1021/acs.langmuir.7b01134</pub-id><pub-id pub-id-type="pmid">28474888</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Serrano</surname> <given-names>L. O.</given-names></name> <name><surname>Burkhart</surname> <given-names>D. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines</article-title>. <source>J. Nanobiotechnol.</source> <volume>15</volume>:<fpage>83</fpage>. <pub-id pub-id-type="doi">10.1186/s12951-017-0319-9</pub-id><pub-id pub-id-type="pmid">29149896</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Efremov</surname> <given-names>R. G.</given-names></name> <name><surname>Nolde</surname> <given-names>D. E.</given-names></name> <name><surname>Vergoten</surname> <given-names>G.</given-names></name> <name><surname>Arseniev</surname> <given-names>A. S.</given-names></name></person-group> (<year>1999</year>). <article-title>A solvent model for simulations of peptides in bilayers. I. Membrane-promoting alpha-helix formation</article-title>. <source>Biophys. J.</source> <volume>76</volume>, <fpage>2448</fpage>&#x02013;<lpage>2459</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3495(99)77400-X</pub-id><pub-id pub-id-type="pmid">10233062</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ejsing</surname> <given-names>C.</given-names></name> <name><surname>Sampaio</surname> <given-names>J.</given-names></name> <name><surname>Surendranath</surname> <given-names>V.</given-names></name> <name><surname>Duchoslav</surname> <given-names>E.</given-names></name> <name><surname>Ekroos</surname> <given-names>K.</given-names></name> <name><surname>Klemm</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>106</volume>, <fpage>2136</fpage>&#x02013;<lpage>2141</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0811700106</pub-id><pub-id pub-id-type="pmid">19174513</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>E.</given-names></name> <name><surname>Rawicz</surname> <given-names>W.</given-names></name></person-group> (<year>1990</year>). <article-title>Entropy-driven tension and bending elasticity in condensed-fluid membranes</article-title>. <source>Phys. Rev. Lett</source>. <volume>64</volume>:<fpage>2094</fpage>. <pub-id pub-id-type="doi">10.1103/PhysRevLett.64.2094</pub-id><pub-id pub-id-type="pmid">10041575</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fait</surname> <given-names>M. E.</given-names></name> <name><surname>Bakas</surname> <given-names>L.</given-names></name> <name><surname>Garrote</surname> <given-names>G. L.</given-names></name> <name><surname>Morcelle</surname> <given-names>S. R</given-names></name> <name><surname>Saparrat</surname> <given-names>M. C. N.</given-names></name></person-group> (<year>2019</year>). <article-title>Cationic surfactants as antifungal agents</article-title>. <source>Appl. Microbiol. Biotechnol.</source> <volume>103</volume>, <fpage>97</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-018-9467-6</pub-id><pub-id pub-id-type="pmid">30374671</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falk</surname> <given-names>N. A.</given-names></name></person-group> (<year>2019</year>). <article-title>Surfactants as antimicrobials: a brief overview of microbial interfacial chemistry and surfactant antimicrobial activity</article-title>. <source>J. Surfact. Deterg.</source> <volume>22</volume>, <fpage>1119</fpage>&#x02013;<lpage>1127</lpage>. <pub-id pub-id-type="doi">10.1002/jsde.12293</pub-id><pub-id pub-id-type="pmid">32336911</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fuller</surname> <given-names>N.</given-names></name> <name><surname>Rand</surname> <given-names>R. P.</given-names></name></person-group> (<year>2001</year>). <article-title>The influence of lysolipids on the spontaneous curvature and bending elasticity of phospholipid membranes</article-title>. <source>Biophys J.</source> <volume>81</volume>, <fpage>243</fpage>&#x02013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3495(01)75695-0</pub-id><pub-id pub-id-type="pmid">11423410</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hannesschlaeger</surname> <given-names>C.</given-names></name> <name><surname>Horner</surname> <given-names>A.</given-names></name> <name><surname>Pohl</surname> <given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Intrinsic membrane permeability to small molecules</article-title>. <source>Chem. Rev.</source> <volume>119</volume>, <fpage>5922</fpage>&#x02013;<lpage>5953</lpage> <pub-id pub-id-type="doi">10.1021/acs.chemrev.8b00560</pub-id><pub-id pub-id-type="pmid">30951292</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname> <given-names>J. M.</given-names></name> <name><surname>Waring</surname> <given-names>A. J.</given-names></name> <name><surname>Separovic</surname> <given-names>F.</given-names></name> <name><surname>Lee</surname> <given-names>K. Y. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Antimicrobial peptides share a common interaction driven by membrane line tension reduction</article-title>. <source>Biophys. J</source>. <volume>111</volume>, <fpage>2176</fpage>&#x02013;<lpage>2189</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2016.10.003</pub-id><pub-id pub-id-type="pmid">27851941</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karpunin</surname> <given-names>D. V.</given-names></name> <name><surname>Akimov</surname> <given-names>S. A.</given-names></name> <name><surname>Frolov</surname> <given-names>V. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Pore formation in lipid membranes containing lysolipids and cholesterol</article-title>. <source>Biol. Membrany</source> <volume>22</volume>, <fpage>429</fpage>&#x02013;<lpage>432</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.11.028</pub-id><pub-id pub-id-type="pmid">19084269</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kollmitzer</surname> <given-names>B.</given-names></name> <name><surname>Heftberger</surname> <given-names>P.</given-names></name> <name><surname>Rappoltbc</surname> <given-names>M.</given-names></name> <name><surname>Pabst</surname> <given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>Monolayer spontaneous curvature of raft-forming membrane lipids</article-title>. <source>Soft Matt.</source> <volume>9</volume>, <fpage>10877</fpage>&#x02013;<lpage>10884</lpage> <pub-id pub-id-type="doi">10.1039/c3sm51829a</pub-id><pub-id pub-id-type="pmid">24672578</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattei</surname> <given-names>B.</given-names></name> <name><surname>Fran&#x000E7;a</surname> <given-names>A.</given-names></name> <name><surname>Riske</surname> <given-names>K.</given-names></name></person-group> (<year>2015</year>). <article-title>Solubilization of binary lipid mixtures by the detergent Triton X-100: the role of cholesterol</article-title>. <source>Langmuir</source> <volume>31</volume>, <fpage>378</fpage>&#x02013;<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1021/la504004r</pub-id><pub-id pub-id-type="pmid">25474726</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michalak</surname> <given-names>Z.</given-names></name> <name><surname>Muzzio</surname> <given-names>M.</given-names></name> <name><surname>Milianta</surname> <given-names>P.</given-names></name> <name><surname>Giacomini</surname> <given-names>R.</given-names></name> <name><surname>Lee</surname> <given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Effect of monoglyceride structure and cholesterol content on water permeability of the droplet bilayer</article-title>. <source>Langmuir</source> <volume>29</volume>, <fpage>15919</fpage>&#x02013;<lpage>15925</lpage> <pub-id pub-id-type="doi">10.1021/la4040535</pub-id><pub-id pub-id-type="pmid">24304231</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mouritsen</surname> <given-names>O. G.</given-names></name> <name><surname>Zuckermann</surname> <given-names>M. J.</given-names></name></person-group> (<year>2004</year>). <article-title>What&#x00027;s so special about cholesterol?</article-title> <source>Lipids</source> <volume>39</volume>, <fpage>1101</fpage>&#x02013;<lpage>1113</lpage>. <pub-id pub-id-type="doi">10.1007/s11745-004-1336-x</pub-id><pub-id pub-id-type="pmid">15726825</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>P&#x000E9;rez-Peinado</surname> <given-names>C.</given-names></name> <name><surname>Dias</surname> <given-names>S. A.</given-names></name> <name><surname>Domingues</surname> <given-names>M. M.</given-names></name> <name><surname>Benfield</surname> <given-names>A. H.</given-names></name> <name><surname>Freire</surname> <given-names>J. M.</given-names></name> <name><surname>R&#x000E1;dis-Baptista</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15-34), antimicrobial peptides from rattlesnake venom</article-title>. <source>J. Biol. Chem</source>. <year>2018</year> <volume>293</volume>, <fpage>1536</fpage>&#x02013;<lpage>1549</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA117.000125</pub-id><pub-id pub-id-type="pmid">29255091</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Severin</surname> <given-names>F. F.</given-names></name> <name><surname>Severina</surname> <given-names>I. I.</given-names></name> <name><surname>Antonenko</surname> <given-names>Y. N.</given-names></name> <name><surname>Rokitskaya</surname> <given-names>T. I.</given-names></name> <name><surname>Cherepanov</surname> <given-names>D. A.</given-names></name> <name><surname>Mokhova</surname> <given-names>E. N.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Penetrating cation/fatty acid anion pair as a mitochondria-targeted protonophore</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A</source>. <volume>107</volume>, <fpage>663</fpage>&#x02013;<lpage>668</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0910216107</pub-id><pub-id pub-id-type="pmid">20080732</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sot</surname> <given-names>J.</given-names></name> <name><surname>Manni</surname> <given-names>M.</given-names></name> <name><surname>Viguera</surname> <given-names>A.</given-names></name> <name><surname>Casta&#x000F1;eda</surname> <given-names>V.</given-names></name> <name><surname>Cano</surname> <given-names>A.</given-names></name> <name><surname>Alonso</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>High-melting lipid mixtures and the origin of detergent-resistant membranes studied with temperature-solubilization diagrams</article-title>. <source>Biophys. J.</source> <volume>107</volume>, <fpage>2828</fpage>&#x02013;<lpage>2837</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2014.10.063</pub-id><pub-id pub-id-type="pmid">25517149</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strandberg</surname> <given-names>E.</given-names></name> <name><surname>Tiltak</surname> <given-names>D.</given-names></name> <name><surname>Ehni</surname> <given-names>S.</given-names></name> <name><surname>Wadhwani</surname> <given-names>P.</given-names></name> <name><surname>Ulrich</surname> <given-names>A. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Lipid shape is a key factor for membrane interactions of amphipathic helical peptides</article-title>, <source>Biochim. Biophys. Acta Biomembranes</source><volume>1818</volume>, <fpage>1764</fpage>&#x02013;<lpage>1776</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2012.02.027</pub-id><pub-id pub-id-type="pmid">22409944</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Subczynski</surname> <given-names>W. K.</given-names></name> <name><surname>Pasenkiewicz-Gierula</surname> <given-names>M.</given-names></name> <name><surname>Widomska</surname> <given-names>J.</given-names></name> <name><surname>Mainali</surname> <given-names>L.</given-names></name> <name><surname>Raguz</surname> <given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>High cholesterol/low cholesterol: effects in biological membranes</article-title>. <source>Cell Biochem. Biophys</source>. <volume>75</volume>, <fpage>369</fpage>&#x02013;<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1007/s12013-017-0792-7</pub-id><pub-id pub-id-type="pmid">28417231</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>&#x00160;ub&#x000ED;k</surname> <given-names>J.</given-names></name> <name><surname>Tak&#x000E1;csov&#x000E1;</surname> <given-names>G.</given-names></name> <name><surname>P&#x00161;en&#x000E1;k</surname> <given-names>M.</given-names></name> <name><surname>Dev&#x000ED;nsky</surname> <given-names>F.</given-names></name></person-group> (<year>2021</year>). <article-title>Antimicrobial activity of amine oxides: mode of action and structure-activity correlation</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>12</volume>, <fpage>139</fpage>&#x02013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.12.2.139</pub-id><pub-id pub-id-type="pmid">409340</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tamba</surname> <given-names>Y.</given-names></name> <name><surname>Ariyama</surname> <given-names>H.</given-names></name> <name><surname>Levadny</surname> <given-names>V.</given-names></name> <name><surname>Yamazaki</surname> <given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Kinetic pathway of antimicrobial peptide magainin 2-induced pore formation in lipid membranes</article-title>. <source>J. Phys. Chem. B</source> <volume>114</volume>, <fpage>12018</fpage>&#x02013;<lpage>12026</lpage>. <pub-id pub-id-type="doi">10.1021/jp104527y</pub-id><pub-id pub-id-type="pmid">20799752</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>E.</given-names></name> <name><surname>Bai</surname> <given-names>P. Y.</given-names></name> <name><surname>Cui</surname> <given-names>D. Y.</given-names></name> <name><surname>Chu</surname> <given-names>W. C.</given-names></name> <name><surname>Hua</surname> <given-names>Y. G.</given-names></name> <name><surname>Liu</surname> <given-names>Q.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Synthesis and bioactivities study of new antibacterial peptide mimics: the dialkyl cationic amphiphiles</article-title>. <source>Eur. J. Med. Chem</source>. <volume>143</volume>, <fpage>1489</fpage>&#x02013;<lpage>1509</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2017.10.044</pub-id><pub-id pub-id-type="pmid">29126736</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>N.</given-names></name> <name><surname>Ma</surname> <given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Recent development of membrane-active molecules as antibacterial agents</article-title>. <source>Eur. J. Med. Chem</source>. <volume>184</volume>:<fpage>111743</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2019.111743</pub-id><pub-id pub-id-type="pmid">31586478</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhelev</surname> <given-names>D.</given-names></name> <name><surname>Needham</surname> <given-names>D.</given-names></name></person-group> (<year>1993</year>). <article-title>Tension-stabilized pores in giant vesicles: determination of pore size and pore line tension</article-title>. <source>Biochim. Biophys. Acta Biomembranes</source> <volume>1147</volume>, <fpage>89</fpage>&#x02013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/0005-2736(93)90319-U</pub-id><pub-id pub-id-type="pmid">8466935</pub-id></citation></ref>
</ref-list>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item><term>ASP</term>
<def><p>Atomic Solvation Parameter</p></def></def-item>
<def-item><term>AB</term>
<def><p>Antibacterial</p></def></def-item>
<def-item><term>AF</term>
<def><p>Antifungal.</p></def></def-item>
</def-list>
</glossary> 
</back>
</article>